TB and HIV Therapeutics: Pharmacology Research Priorities.

TB and HIV Therapeutics: Pharmacology Research Priorities.

Item
http://www.wikidata.org/entity/Q36099838
Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein.Impact of lopinavir-ritonavir or nevirapine on bedaquiline exposures and potential implications for patients with tuberculosis-HIV coinfection.The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo.Evaluation of pharmacokinetic interaction between PA-824 and midazolam in healthy adult subjects.Prevalence and patterns of multimorbidity among tuberculosis patients in Brazil: a cross-sectional studyMajor differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe.Pharmacologic considerations in use and development of antituberculosis drugs.Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat In Vitro
P2860

TB and HIV Therapeutics: Pharmacology Research Priorities.

Item
http://www.wikidata.org/entity/Q36099838
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
TB and HIV Therapeutics: Pharmacology Research Priorities.
@ast
TB and HIV Therapeutics: Pharmacology Research Priorities.
@en
type
label
TB and HIV Therapeutics: Pharmacology Research Priorities.
@ast
TB and HIV Therapeutics: Pharmacology Research Priorities.
@en
prefLabel
TB and HIV Therapeutics: Pharmacology Research Priorities.
@ast
TB and HIV Therapeutics: Pharmacology Research Priorities.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932
P356
P1433
P1476
TB and HIV Therapeutics: Pharmacology Research Priorities.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932